Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.22
13.08.21
-
13.08.22
-3.95%
22.08.21

Risky Investment
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€91.50
10.08.21
-
10.08.22
-42.25%
10.08.22

buy
Repligen Corp.

Start price
Target price
Perf. (%)
€210.00
03.08.21
-
03.08.22
13.21%
03.08.22

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€132.45
12.07.21
-
12.07.22
-61.65%
13.03.22

buy
Repligen Corp.

Start price
Target price
Perf. (%)
€174.95
08.07.21
-
08.07.22
-2.46%
08.07.22

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.17
08.07.21
-
08.07.22
30.25%
08.07.22

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€97.50
08.07.21
-
08.07.22
11.30%
08.07.22

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€132.55
08.07.21
€150.00
08.07.22
-76.58%
29.04.22

Future proof or reliable business model
Top 10 in its market
Innovative
Growths faster than the competition
buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€24.00
08.07.21
-
08.07.22
-7.29%
08.07.22

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€146.45
08.07.21
-
08.07.22
2.31%
08.07.22

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€54.60
08.07.21
-
08.07.22
-37.34%
21.05.22

buy
Pra Health

Start price
Target price
Perf. (%)
€141.00
28.06.21
€200.00
28.06.22
-0.71%
12.07.21

Could be worthwhile Investment >10% per year
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€72.60
28.06.21
€120.00
28.06.22
-21.07%
12.07.21

Could be worthwhile Investment >10% per year
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€146.55
28.06.21
€200.00
28.06.22
-3.62%
12.07.21

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€48.00
28.06.21
€75.00
28.06.22
-2.98%
12.07.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.95
16.06.21
€75.00
16.06.22
2.24%
28.06.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
buy
Invitae Corp

Start price
Target price
Perf. (%)
€25.10
09.06.21
€30.00
09.06.22
-89.88%
10.06.22

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€128.00
30.05.21
€96.00
30.05.22
-32.52%
20.12.21

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€71.50
03.05.21
€78.00
03.05.22
2.80%
04.05.22

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€158.00
04.04.21
€75.00
04.04.22
-56.02%
05.04.22

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€163.98
20.03.21
-
20.03.22
-46.87%
21.12.21

Could be very worthwhile Investment >20% year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€240.00
25.01.21
€350.00
25.01.22
-73.33%
26.01.22

Could be very worthwhile Investment >20% year
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
buy
Invitae Corp

Start price
Target price
Perf. (%)
€48.87
11.12.20
€50.00
-14.92%
17.12.20